Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell ImmunotherapiesLaurent Poirot, Julianne Smith, Brian Philip et al.|Cancer Research|2015Cited by 600
megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineeringSandrine Boissel, Andrew M. Scharenberg, Jay Shendure et al.|Nucleic Acids Research|2013Cited by 174
Coupling endonucleases with DNA end–processing enzymes to drive gene disruptionMichael T. Certo, Andrew M. Scharenberg, Kamila Gwiazda et al.|Nature Methods|2012Cited by 107
Pre-TCRα supports CD3-dependent reactivation and expansion of TCRα-deficient primary human T-cellsRomán Galetto, Andrew M. Scharenberg, Céline Lebuhotel et al.|Molecular Therapy — Methods & Clinical Development|2014Cited by 10
Treatment of B cells malignancies with anti-CD19 CAR+, TCR-, CD52- allogeneic T cellsCécile Schiffer Mannioui, Andrew M. Scharenberg, Laëtitia Lemaire et al.|Journal for ImmunoTherapy of Cancer|2013Cited by 1